New patients 0800 52 00 161 / Existing patients: 0207 078 4868 (Mon-Fri, 9am-4pm)
Patient Portal
UK
Brasil Chile Deutschland España France International Italia Panamá Portugal Russia UK
Save £200 on your treatment cycle. Book a Fertility Treatment Consultation before 15th July to qualify.  Book Now
IVI UK
    • CONSULTATION

      • Fertility Treatment Consultation
      • Your First Visit
      • Starting Fertility Treatment
    • FERTILITY TESTING

      • Fertility Assessments
      • Female Fertility Assessment
      • Couple's Fertility Assessment
      • Same-Sex Female Couple's Fertility Assessment
      • Private Semen Analysis London
    • FERTILITY TREATMENTS

      • In Vitro Fertilisation (IVF)
      • Intrauterine Insemination (IUI)
      • Reciprocal IVF
      • IVF with Donor Eggs
      • Fertility Treatment for NHS Patients
    • ANSWERS TO YOUR QUESTIONS

      • Causes of Infertility
      • Fertility Treatment After 40
      • Fertility Treatment for Single Women
      • Fertility treatment for LGBTQ+ couples
      • Endometriosis
      • Polycystic Ovary Syndrome (PCOS) Guide
      • Events on demand
    • ADDITIONAL SERVICES
      • Intracytoplasmic Sperm Injection (ICSI)
      • EmbryoScope
      • Vitrification of oocytes
    • GENETIC TESTS

      • PGT-A / PGS
      • PGT-M / PGT-SR
  • Egg Freezing
    • UK Treatment

      • London
  • Prices
  • Success Rates
    • SPECIALISTS

      • Clinical team
    • IVI BRAND

      • Why Choose IVI
      • The Language of fertility
    • NEWS & UPDATES

      • Blog
      • Press room
Make an appointment
  • CONSULTATION

    • Fertility Treatment Consultation
    • Your First Visit
    • Starting Fertility Treatment
  • FERTILITY TESTING

    • Fertility Assessments
    • Female Fertility Assessment
    • Couple's Fertility Assessment
    • Same-Sex Female Couple's Fertility Assessment
    • Private Semen Analysis London
  • FERTILITY TREATMENTS

    • In Vitro Fertilisation (IVF)
    • Intrauterine Insemination (IUI)
    • Reciprocal IVF
    • IVF with Donor Eggs
    • Fertility Treatment for NHS Patients
  • ANSWERS TO YOUR QUESTIONS

    • Causes of Infertility
    • Fertility Treatment After 40
    • Fertility Treatment for Single Women
    • Fertility treatment for LGBTQ+ couples
    • Endometriosis
    • Polycystic Ovary Syndrome (PCOS) Guide
    • Events on demand
  • ADDITIONAL SERVICES
    • Intracytoplasmic Sperm Injection (ICSI)
    • EmbryoScope
    • Vitrification of oocytes
  • GENETIC TESTS

    • PGT-A / PGS
    • PGT-M / PGT-SR
Egg Freezing
  • UK Treatment

    • London
Prices
Success Rates
  • SPECIALISTS

    • Clinical team
  • IVI BRAND

    • Why Choose IVI
    • The Language of fertility
  • NEWS & UPDATES

    • Blog
    • Press room
Free call
Contact us

4 April 2019

Extracellular vesicles may help improve success rates of assisted reproduction

Home Press room Extracellular vesicles may help improve success rates of assisted reproduction

IVIRMA CONGRESS

  • These particles are a promising research tool due to their fundamental role in the communication between embryo and endometrium and their potential to serve as a biomarker

MALLORCA, 4th APRIL, 2019

Since the beginning of reproductive medicine, the idea of “a better embryo equalling better pregnancy outcomes” has been taken as an unquestionable truth. As a result, special focus has been placed on embryology laboratories to improve embryo selection methods and to opt for those embryos with the greatest potential for implantation. In this sense, the poster presented by IVI at the 8th International IVIRMA Congress on extracellular vesicles opens up a new method to improve this selection and, therefore, to increase success rates in reproductive treatments.

The poster, entitled “Extracellular vesicles can be isolated from culture media with and without exposure to human preimplantation embryos”, led by Diego Marin, PhD student at the IVIRMA group’s headquarters in New Jersey, and Dr. Richard T. Scott, IVIRMA’s CEO and project mentor, was created with the aim of searching for a biomarker that allows the optimization of the embryo selection process using a non-invasive method, and thus increasing embryo implantation rates, in this case euploids –those containing 46 normal chromosomes–, which currently stand at 70%.

“Extracellular vesicles are particles derived from bilayer membrane cells that secrete molecules and, as has been demonstrated, play a fundamental role in intercellular communication. Given that the dialogue between the embryo and the endometrium is crucial for correct implantation and a normal pregnancy to term, we want to demonstrate that these extracellular vesicles secreted by the embryo before its implantation play a central role in this communication and, therefore, can become potential biomarkers for embryonic reproductive competency”, said Prof. Juan Antonio García – Velasco, Scientific Director of the 8th International IVIRMA Congress.

This is a fairly novel research topic –only studied for two years–, and therefore, in the long term, the aim is to identify these vesicles, isolate them from the culture medium and analyse them to see the effects they can have on the embryo, in this case, an euploid embryo, thus optimizing the potential of these vesicles in the field of assisted reproduction.

“Although there are studies on the relationship between these vesicles and their application in the treatment of kidney disease or tumoural conditions, it had not been applied in the field of reproductive medicine until recently. Embryonic extracellular vesicles offer an encouraging and non-invasive opportunity to assess the viability of the embryo that could help improve embryo selection and understand the molecular dialogue between embryo and endometrium, significantly increasing pregnancy outcomes, by combining this promising tool with other diagnostic technologies. However, more complex studies are needed to implement their profile as a diagnostic test for embryo selection”, added Prof. García – Velasco.

Searching for the reproductive panacea

Due to its immediate accessibility, the embryo’s morphology has become the standard method for embryo selection. Later, Preimplantation Genetic Testing for Aneuploidy (PGT-A) revolutionized the field by taking embryo selection beyond its appearance and focusing on its genetic makeup. Thus, it could be demonstrated that the transfer of chromosomally normal embryos leads to higher implantation rates, lower rates of miscarriage and shorter times to achieve pregnancy.

As a result, several attempts have been made to find solid and measurable variables that can be established as biomarkers of embryonic competency and thus further improve reproductive outcomes. At this point we have the implementation of devices such as the EmbryoScope, which has allowed the study of morphokinetic parameters.

Morphology, genetic constitution and morphokinetic parameters, despite the remarkable evolutionary improvement they have offered, outline the current implantation rate scenario: About a third of chromosomally normal embryos still fail to implant in the uterus.

“Now, we go a step further and focus on the study of extracellular vesicles with the main objective of increasing the rate of embryo implantation with detailed knowledge of the possibilities of these particles and their influence on the reproductive process”, concluded Prof. García – Velasco.

Share on social networks

twitter facebook

Share on social networks

twitter facebook

PRESS ROOM CONTACTS

  • Farrer Kane
  • Email: ivi@farrerkane.com
  • Phone number: +44 (0) 7795 203181
  • 83 Wimpole Street, London W1G 9RQ

Request more information, no obligation

Sending

Thank you,

One of our agents will contact you shortly. Meanwhile, have a look at our Virtual Events on Demand, in which you can find exclusive content about the fertility treatments we offer.

Access the fertility days

Experts in fertility

  • Infertility Treatments
  • Fertility Diagnostic Assessments
  • IVI London
  • FAQs

Learn about us

  • Corporate information
  • IVIRMA Global Education
  • IVIRMA Innovation
  • Jobs at IVI
  • Legal Notice
  • Privacy Policy
  • Our Cookies Policy and Notice
  • Complaints Policy
  • Treatment Terms & Conditions
  • Internal Information Channel
  • Press Enquiries: ivi@farrerkane.com
  • logo
  • logo
  • logo
  • logo
  • logo

Head Offices

  • Calle Colón 1, 4ª planta, 46004 Valencia. España.

London Clinic

  • 83 Wimpole Street W1G 9RQ - London